Recent publication in the Journal of Molecular Diagnostics

Dr. Christopher Corless and the Knight Diagnostic Laboratories team has shown that Copy Number Alterations (CNAs) can be identified in amplicon-based targeted sequencing data, and that their detection can be optimized by ensuring adequate tumor content and read coverage. Their results were published as the feature article in the January publication of the Journal of Molecular Diagnostics.